211 related articles for article (PubMed ID: 18620013)
1. Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s).
Suzuki S; Uchida D; Koide H; Tanaka T; Noguchi Y; Saito Y; Tatsuno I
Peptides; 2008 Oct; 29(10):1767-72. PubMed ID: 18620013
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin responders have a high prevalence of hypertension and insulin resistance in spite of a lower secretion of cortisol in subclinical Cushing's syndrome.
Suzuki S; Uchida D; Koide H; Suyama K; Tanaka T; Noguchi Y; Saito Y; Tatsuno I
Mol Med Rep; 2009; 2(1):115-20. PubMed ID: 21475800
[TBL] [Abstract][Full Text] [Related]
3. A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma.
Suzuki S; Uchida D; Koide H; Suyama K; Shibata T; Yoshida T; Tanaka T; Noguchi Y; Saito Y; Tatsuno I
Peptides; 2008 Dec; 29(12):2225-31. PubMed ID: 18838094
[TBL] [Abstract][Full Text] [Related]
4. Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?
Joubert M; Louiset E; Rego JL; Contesse V; Kong LC; Benhaim A; Mittre H; Lefebvre H; Reznik Y;
Clin Endocrinol (Oxf); 2008 May; 68(5):692-9. PubMed ID: 17980016
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
6. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
7. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
[TBL] [Abstract][Full Text] [Related]
8. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
Louiset E; Contesse V; Groussin L; Cartier D; Duparc C; Perraudin V; Bertherat J; Lefebvre H
J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
[TBL] [Abstract][Full Text] [Related]
9. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.
Gagliardi L; Hotu C; Casey G; Braund WJ; Ling KH; Dodd T; Manavis J; Devitt PG; Cutfield R; Rudzki Z; Scott HS; Torpy DJ
Clin Endocrinol (Oxf); 2009 Jun; 70(6):883-91. PubMed ID: 19018784
[TBL] [Abstract][Full Text] [Related]
10. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
Lacroix A; Tremblay J; Touyz RM; Deng LY; Lariviere R; Cusson JR; Schiffrin EL; Hamet P
J Clin Endocrinol Metab; 1997 Aug; 82(8):2414-22. PubMed ID: 9253310
[TBL] [Abstract][Full Text] [Related]
11. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
12. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Mune T; Murase H; Yamakita N; Fukuda T; Murayama M; Miura A; Suwa T; Hanafusa J; Daido H; Morita H; Yasuda K
J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
Klose M; Jørgensen K; Kristensen LØ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
[TBL] [Abstract][Full Text] [Related]
14. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
16. A marked difference in the vasopressin responsiveness between the adrenal glands in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia.
Miyata M; Yoshida M; Shinoda J; Sasano H; Oiso Y
Intern Med; 2013; 52(10):1073-8. PubMed ID: 23676593
[TBL] [Abstract][Full Text] [Related]
17. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
Iida K; Kaji H; Matsumoto H; Okimura Y; Abe H; Fujisawa M; Kamidono S; Chihara K
Clin Endocrinol (Oxf); 1997 Dec; 47(6):739-45. PubMed ID: 9497882
[TBL] [Abstract][Full Text] [Related]
18. Unilateral macronodular adrenal hyperplasia as an unusual cause of Cushing's syndrome--a case study.
Agboola-Abu CF; Garba MR; Elesha SO; Obiora AA; Kuku SF
West Afr J Med; 1999; 18(2):124-9. PubMed ID: 10504870
[TBL] [Abstract][Full Text] [Related]
19. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.
Libé R; Coste J; Guignat L; Tissier F; Lefebvre H; Barrande G; Ajzenberg C; Tauveron I; Clauser E; Dousset B; Bertagna X; Bertherat J; Groussin L
Eur J Endocrinol; 2010 Jul; 163(1):129-38. PubMed ID: 20378721
[TBL] [Abstract][Full Text] [Related]
20. ARMC5 mutations in a large French-Canadian family with cortisol-secreting β-adrenergic/vasopressin responsive bilateral macronodular adrenal hyperplasia.
Bourdeau I; Oble S; Magne F; Lévesque I; Cáceres-Gorriti KY; Nolet S; Awadalla P; Tremblay J; Hamet P; Fragoso MC; Lacroix A
Eur J Endocrinol; 2016 Jan; 174(1):85-96. PubMed ID: 26604299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
